- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Hunan Children's Hospital
Total 8158 results
-
Hunan Province Tumor HospitalNot yet recruitingLung Adenocarcinoma | ALK Gene Mutation | ImmunotherapyChina
-
Hunan Province Tumor HospitalRecruitingSmall-cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon-Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalCompletedNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalCompleted
-
Hunan Province Tumor HospitalCompletedNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalCompleted
-
Hunan Province Tumor HospitalCompletedCarcinoma, Non-small Cell LungChina
-
Hunan Province Tumor HospitalCompletedNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalCompletedExtensive Stage Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalCompletedUncommon Pathological Types of Lung CancerChina
-
Hunan Province Tumor HospitalCompletedNon-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIIA | Non-small Cell Lung Cancer Stage IIChina
-
Shaare Zedek Medical CenterThe Hospital for Sick Children; Rambam Health Care Campus; Children's Hospital... and other collaboratorsCompleted
-
Children's Hospital Medical Center, CincinnatiThe Hospital for Sick ChildrenCompleted
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingAdvanced Lung Squamous Cell CarcinomaChina
-
Hunan Province Tumor HospitalRecruitingSmall Cell Lung CancerChina
-
Hunan Provincial People's HospitalNot yet recruiting
-
Hunan Provincial People's HospitalRecruitingTraumatic Optic NeuropathyChina
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingCarcinoma, Non-Small Cell Lung | EGFR Gene MutationChina
-
Hunan Province Tumor HospitalCompletedNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalCompletedNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalCompletedNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalCompletedNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalCompletedExtensive Stage Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalCompletedExtensive Stage Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalCompletedNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalCompletedProgression | Advanced Non-small Cell Lung Cancer | First Line Treatment | Carcinoembryonic Antigen | Thioredoxin Reductase ActivityChina
-
Hunan Province Tumor HospitalCompletedCarcinoma, Non-small Cell LungChina
-
Hunan Provincial People's HospitalUnknown
-
Hunan Province Tumor HospitalCompletedNon-small Cell Lung Cancer | Benign Neoplasm of LungChina
-
Hunan Province Tumor HospitalUnknown
-
Hunan Province Tumor HospitalUnknownNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruiting
-
Hunan Province Tumor HospitalRecruitingAdvanced Solid Tumors or LymphomasChina
-
Hunan Province Tumor HospitalRecruitingExtensive-stage Small-cell Lung CancerChina
-
Hunan Province Tumor HospitalNot yet recruiting
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon-Small Cell Lung CancerChina
-
Hunan Provincial People's HospitalRecruitingTachyarrhythmia | Brady-tachy Syndrome | Bradyarrhythmia | Bradycardia; Syncope | AVB - Atrioventricular Block | Tachycardia BradycardiaChina
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingNon Small Cell Lung CancerChina
-
Hunan Province Tumor HospitalRecruitingReal World Study of First Line Crizotinib for ALK Rearranged Non-squamous Non-small Cell Lung CancerNon-small Cell Lung CancerChina